Moreover, the combination of HOTAIRM1/miR-196b expression yielded a simple risk score which enabled IR-AML patients to be classified in three prognostic groups; in fact, the risk score also had an impact in the FAVmol subgroup. The gene discussed is HOTAIRM1; the disease is acute myeloid leukemia.